New Updates to Leading aCGH Data Analysis Software
Product News Mar 26, 2014
Oxford Gene Technology (OGT) has announced the latest version (4.5.3) of its class-leading CytoSure™ Interpret Software. Complimentary with all CytoSure array purchases, CytoSure Interpret Software is a powerful and easy-to-use package for the analysis of aCGH data, the gold-standard for copy number variation (CNV) detection.
Offering an impressive combination of advanced features, including Automatic Aberration Classification, the software allows the choice of standardized or customized user-defined data analysis.
With this latest version, OGT has introduced several innovative new features that further facilitate and standardize the data analysis workflow in order to deliver rapid access to meaningful results.
By using information available in online databases such as DECIPHER and settings defined by the user, the Automatic Aberration Classification enables users to configure the software to automatically perform an initial classification of any detected CNV, accelerating analysis and standardizing the interpretation process.
CytoSure Interpret Software allows simultaneous access to sample and experiment information across a network, providing the potential for labs on multiple sites to access a central database. In situations where IT infrastructures don’t permit this, the software now provides the additional functionality for exporting sample and experiment information into other databases, further facilitating sharing of case information and aberration calls.
In addition to the free text phenotype field, users are also now able to use Standardized Phenotype (Human Phenotype Ontology - HPO) terms to simplify and normalize the phenotype description process via a HPO Phenotype Selector window.
Dr Ruth Burton, Product Manager for CytoSure said “CytoSure Interpret Software continues to be cited as a decisive factor when purchasing CytoSure arrays and was a major contributor to our recent success in a competitive NHS tender for the supply of oligo-based arrays for cytogenetics research. Our dedicated software development team are continually implementing enhanced features and capabilities in response to new product development and customer feedback, reflecting the overall OGT strategy to provide the most effective and high quality products, services and support.”